VitalSight is a HIPAA-compliant, Medicare-reimbursable home blood pressure monitoring solution that generally comes at no cost to the patient, depending on their coverage
OMRON Healthcare, Inc., the global leader in personal heart health and wellness technology, and Mount Sinai Health System, New York City’s largest academic medical system, have teamed together to offer patients the new VitalSight™ home blood pressure monitoring solution. Mount Sinai recently rolled out the VitalSight program to support the needs of their patients with hypertension.
“We’re excited to collaborate with such a prestigious healthcare institution as Mount Sinai, who played an instrumental role in shaping the value of VitalSight from early in its development. Now, they are leading the way for patients to use VitalSight from the privacy of their home, while staying closely connected to their physician,” explained OMRON Healthcare President and CEO Ranndy Kellogg.
VitalSight is the newest addition to the comprehensive line of OMRON Healthcare home blood pressure monitors (the #1 doctor and pharmacist recommended brand1,2) designed to advance the company’s mission of Going for Zero™ — the elimination of heart attack and stroke. The VitalSight kit complements Mount Sinai’s commitment to remotely monitor patients as part of its recent telehealth initiative, especially as providers care for COVID-19 patients who are recovering at home.
The effort to provide VitalSight to patients is led by Dr. Rob Fields, SVP and Chief Medical Officer for Population Health at Mount Sinai, and a dedicated team of clinical pharmacists, who are responsible for the day-to-day management of the program and coordination with physicians to ensure that patients receive individualized care. “The ability to monitor patients at home during the pandemic – and on an ongoing basis – is critical. Our collaboration with OMRON Healthcare helps make patients active participants in their own health care and extends the reach of clinicians, who receive a continuous stream of their patients’ real-time health data so that they can proactively intervene as necessary,” he said. “Additionally, we are focusing first on our most vulnerable patients, who bear the consequences of disparities in care – in part, due to lack of technology access. This program requires no technology and comes at no cost for the device, with little-to-no cost for service.”
Source: Company Press Release